Exact Mass: 431.0303

Exact Mass Matches: 431.0303

Found 61 metabolites which its exact mass value is equals to given mass value 431.0303, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Rimsulfuron

C14H17N5O7S2 (431.0569)

CONFIDENCE standard compound; EAWAG_UCHEM_ID 130 EAWAG_UCHEM_ID 130; CONFIDENCE standard compound

Bensultap

Thiobenzenesulphonic acid S,s-(2-(dimethylamino)trimethylene) ester

C17H21NO4S4 (431.0353)

4-Ketoanhydrochlortetracycline

4-Ketoanhydrochlortetracycline; 4-Ketoanhydro-7-chlorotetracycline; 4-Oxoanhydrochlortetracycline; 4-Dedimethylamine-4-oxo-anhydro-7-Cl-tetracycline

C20H14ClNO8 (431.0408)

Benzthiazide

6-Chloro-1,1-dioxo-3-(phenylmethylsulphanylmethyl)-4H-benzo[e][1,2,4]thiadiazine-7-sulphonamide

C15H14ClN3O4S3 (430.9835)

Benzthiazide is used to treat hypertension and edema. Like other thiazides, benzthiazide promotes water loss from the body (diuretics). They inhibit Na+/Cl- reabsorption from the distal convoluted tubules in the kidneys. Thiazides also cause loss of potassium and an increase in serum uric acid. Thiazides are often used to treat hypertension, but their hypotensive effects are not necessarily due to their diuretic activity. Thiazides have been shown to prevent hypertension-related morbidity and mortality although the mechanism is not fully understood. Thiazides cause vasodilation by activating calcium-activated potassium channels (large conductance) in vascular smooth muscles and inhibiting various carbonic anhydrases in vascular tissue. C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic

Clionamide

C19H18BrN3O4 (431.0481)

Phosphonoformyl-CMP

Phosphonoformyl-CMP; CMP-5-phosphonoformate

C10H15N3O12P2 (431.0131)

Pimasertib

C15H15FIN3O3 (431.0142)

C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C69145 - Mitogen-Activated Protein Kinase Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor Pimasertib (AS703026) is a highly selective, ATP non-competitive allosteric orally available MEK1/2 inhibitor[1][2].

[[(2r,3s,4r,5r)-5-(4-Azanyl-2-Oxidanylidene-Pyrimidin-1-Yl)-3,4-Bis(Oxidanyl)oxolan-2-Yl]methoxy-Oxidanyl-Phosphoryl]oxy-(2-Hydroxyethyl)phosphinic Acid

C11H19N3O11P2 (431.0495)

2-Fluorobutyl 2-(8-azabicyclo[3.2.1]octan-1-yl)-5-iodobenzoate

2-Fluorobutyl 2-(8-azabicyclo[3.2.1]octan-1-yl)-5-iodobenzoic acid

C18H23FINO2 (431.0758)

N-(3,5-Dichloro-1-oxido-4-pyridinyl)-8-methoxy-2-(trifluoromethyl)-5-quinoline carboxamide

N-(3,5-dichloro-1-hydroxy-1,4-dihydropyridin-4-ylidene)-8-methoxy-2-(trifluoromethyl)quinoline-5-carboxamide

C17H10Cl2F3N3O3 (431.0051)

Ioflupane

Methyl 8-(3-fluoropropyl)-3-(4-iodophenyl)-8-azabicyclo[3.2.1]octane-2-carboxylic acid

C18H23FINO2 (431.0758)

Ferric Maltol

Iron(3+) ion tris(2-methyl-4-oxo-4H-pyran-3-olic acid)

C18H15FeO9 (431.0065)

BTZ043

2-[(3S)-3-methyl-1,4-dioxa-8-azaspiro[4.5]decan-8-yl]-8-nitro-6-(trifluoromethyl)-1,3-benzothiazin-4-one

C17H16F3N3O5S (431.0763)

TRANS-4-[2-(1-FERROCENYL)VINYL]-1-METHYLPYRIDINIUM IODIDE

C18H18FeIN (430.9833)

2-[(6-amino-1-hydroxy-3-sulpho-2-naphthyl)azo]benzoic acid, sodium salt

C17H11N3Na2O6S (431.0164)

Ammonium perfluorocaprilate

C8H4F15NO2 (431.0003)

N-(2-CARBOXY-4,5-DICHLOROBENZOYL)-(-)-10,2-CAMPHORSULTAM

C18H19Cl2NO5S (431.0361)

N-(4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)-3-(4-(PYRIDIN-3-YLOXY)PHENYL)-1H-1,2,4-TRIAZOL-5-AMINE

C20H13ClF3N5O (431.0761)

ETHYL [3-(4-BROMOPHENYL)-4,6-DIMETHOXY-1H-INDOL-7-YL]-OXO-ACETATE

C20H18BrNO5 (431.0368)

(S)-1-(tert-Butoxycarbonyl)-2-(4-iodobenzyl)pyrrolidine-2-carboxylic acid

C17H22INO4 (431.0594)

1-[4-BROMO-2-(HYDROXYMETHYL)PHENYL]-4-(DIMETHYLAMINO)-1-(4-FLUOROPHENYL) BUTAN-1-OL HYDROCHLORIDE

C19H24BrClFNO2 (431.0663)

CYCLOPENTADIENYL(FLUORENE)IRON HEXAFLUOROPHOSPHATE

C18H14F6FeP (431.0087)

(3S,5S,6R)-TERT-BUTYL 3-BROMO-2-OXO-5,6-DIPHENYLMORPHOLINE-4-CARBOXYLATE

C21H22BrNO4 (431.0732)

Acetic acid, 2-[[5-bromo-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]-, ethyl ester

C19H18BrN3O2S (431.0303)

Disperse Orange 97

C18H11Cl2N5O4 (431.0188)

ethyl 5-(benzyloxy)-6-broMo-2-(2-hydroxyethyl)-1-Methyl-1H-indole-3-carboxylate

C21H22BrNO4 (431.0732)

4-Iodo-4,4-dimethoxytriphenylamine

C20H18INO2 (431.0382)

Ferric Maltol

C18H15FeO9 (431.0065)

B - Blood and blood forming organs > B03 - Antianemic preparations > B03A - Iron preparations > B03AB - Iron trivalent, oral preparations D006401 - Hematologic Agents > D006397 - Hematinics > D005290 - Ferric Compounds

Ioflupane I-123

C18H23FINO2 (431.0758)

V - Various > V09 - Diagnostic radiopharmaceuticals > V09A - Central nervous system > V09AB - Iodine (123i) compounds C1446 - Radiopharmaceutical Compound

[(1s)-1-(5-Chloro-1-Benzothien-3-Yl)-2-(2-Naphthylamino)-2-Oxoethyl]phosphonic Acid

C20H15ClNO4PS (431.0148)

[5-(4-Chlorophenyl)-1,3,4-oxadiazol-2-yl]-[4-(1-piperidinylsulfonyl)phenyl]methanone

C20H18ClN3O4S (431.0706)

3-Nitro-4-[[4-(2-oxolanylmethyl)-5-thiophen-2-yl-1,2,4-triazol-3-yl]thio]benzamide

C18H17N5O4S2 (431.0722)

N-[4-(2,5-dimethoxyphenyl)-2-thiazolyl]-2-[(4-nitrophenyl)thio]acetamide

C19H17N3O5S2 (431.061)

2-(2,3-Dihydro-1,4-benzodioxin-6-ylsulfonylamino)benzoic acid thiophen-2-ylmethyl ester

C20H17NO6S2 (431.0497)

N-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]-2-(trifluoromethyl)benzamide

C17H10F9NO2 (431.0568)

(2S,3S,4S,5R)-6-[[3-Amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-5-yl]amino]-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H15Cl2N5O6 (431.0399)

(2E,5Z)-5-[(3-bromophenyl)methylidene]-2-[(E)-(1,7,7-trimethyl-2-bicyclo[2.2.1]heptanylidene)hydrazinylidene]-1,3-thiazolidin-4-one

C20H22BrN3OS (431.0667)